Examining the pros and cons of semaglutide A new study finds lowered risk of 42 health outcomes and increased risk of 19 for people using GLP-1RAs, highlighting the ‘far-reaching potential’ of the drugs.
How long does immunity last after a COVID infection? Dr Lara Herrero and Wesley Freppel assess the latest evidence, including the impact vaccination and emerging variants can have.
Tongue cancer diagnoses on the rise Rates have spiked in cohorts not traditionally at risk of the cancer, especially younger women with no history of smoking or heavy drinking.
Full details of incoming CDM changes revealed New MBS fees, transition arrangements and referral pathways have been unveiled. The RACGP President said he’s been left frustrated by the delay, but ‘at least we now have clarity’.
One of the many faces of codeine addiction Jessica Khachan lives in Sydney with her husband and two kids, who are 14 and 12, in what she describes as ‘a normal suburban household’. She is also one of the increasing number of Australians with a history of codeine addiction.
‘Disappointing’: Bulk-billing loading allocation revealed The incentive will be split 50:50 between GPs and practices, but the RACGP has hit back, saying the Government ‘hasn’t listened’.
Practical details of new bulk billing program revealed New DoHAC factsheets explain how the controversial incentives program will work, how GPs’ earnings could change, and accreditation exemptions.
Shingles vaccine linked to dementia risk reduction The new research found those vaccinated had their risk of new dementia diagnoses reduced by 20% over seven years.
Detail of new women’s health MBS items explained With the items’ launch just days away, details of the menopause assessments have been released, including its rebates and mandatory clinical activities.
PBS restrictions placed on diabetes medicines GPs now need to gain additional approval prior to starting patients on all GLP-1 RAs, including semaglutide.